Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E. - Wikidata - awgldk - TriplyDB

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

http://www.wikidata.org/entity/Q36624194

about

HIV-Host Interactions: Implications for Vaccine Design Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases Latency reversal and viral clearance to cure HIV-1.Current views on the potential for development of a HIV vaccine.MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection.Natural Killer Cell Evasion Is Essential for Infection by Rhesus Cytomegalovirus Cross-Species Rhesus Cytomegalovirus Infection of Cynomolgus Macaques.Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion.DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.International AIDS Society global scientific strategy: towards an HIV cure 2016.Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection.New challenges in therapeutic vaccines against HIV infection.I've got algorithm: predicting tumor and autoimmune peptide targets for CD8+ T cells.Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque.Kill: boosting HIV-specific immune responses.The role of MHC class Ib-restricted T cells during infection.Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes.NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection.Polyvalent vaccine approaches to combat HIV-1 diversity Recent advances in Major Histocompatibility Complex (MHC) class I antigen presentation: Plastic MHC molecules and TAPBPR-mediated quality control.Unusual antigen presentation offers new insight into HIV vaccine design.Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer.CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination.Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.Novel viral vectors in infectious diseases.Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells.Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity.Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans.HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection.Graph-based optimization of epitope coverage for vaccine antigen design.

P2860

Q26765966-ED50A04A-4A25-4313-88B4-75EE55547132 Q28079186-6AA5C213-0B97-48E2-B412-BD7ABEA9240C Q30248766-E92FFB51-EF69-413B-AF8B-F2B46BF4BF38 Q30397595-BB67EE43-B370-4FD5-9B92-855F65B5D071 Q33699588-4B078ABF-8A4D-4E7A-B1FB-E5FB641B6980 Q33869332-3EB11DD4-6EFC-4C3C-9980-ADEAB3DC4042 Q36106653-9C141BB0-C333-4F15-8A27-976C4F7DD67E Q36118554-85ECE46D-C7BD-4806-8AF2-0FC3D2437394 Q36187466-BE829A03-6D41-4634-9B8A-67256C8BBAE6 Q37221660-DC8D93B6-B605-46F4-B019-F9320BF8E74A Q37362291-BCE03474-C490-4E4E-B2BF-CBAEF5154651 Q37395174-EFF52D46-29C5-4DB3-8260-03D442D4FACD Q37573037-D7649F61-2C17-461F-A5BC-BE81CD0D141D Q37621530-425CE043-2E01-4230-8EAB-E1924B390F26 Q37628079-96896279-6442-4C78-98C4-A62D699E6C76 Q37661770-1FE4F3E8-3073-4F8E-AA69-3F07E32784BB Q38433251-EA188F74-95EA-4BAD-9563-336BE9070575 Q38692205-E45197F7-3770-42F5-9197-9D6913EB5172 Q38731152-13A0DF40-5CB6-4EAB-B8AB-7A0D1EB74966 Q38777005-F6102C34-0662-4D1F-B5A7-AA11069F87B2 Q38786450-58500BA1-2ACE-45B1-8296-A63F42C52AC7 Q38800533-7D10D631-11FB-4E3E-AD9C-D1520BED1719 Q38883507-3026872A-6940-452A-B8BC-DC7873B4F239 Q38985750-56F6F9F3-7770-4B1C-991D-8847A5572FBE Q39056737-D7FC63CA-52E8-4F0A-BEA0-6889FD4577E4 Q39108740-478A7F48-9173-4EDB-BCEF-CF91707629EA Q39181144-F4284B2E-5F1F-4A19-B872-9C70B524318F Q39307257-E342F2B6-CC87-43FB-9340-55A3EF406E58 Q39387367-C886430E-27D5-4B66-97E7-AE4ACF9DC388 Q39451749-C3967C46-B76C-49AA-B7AA-B2D672C9822F Q40047250-2572F44F-07D2-4886-A442-BD471161997C Q40059020-3940D4D7-7039-47ED-8EF1-625D40EA8AFC Q40113278-1880C502-7A16-465A-8EDA-EB0D4664DF50 Q40118193-C29A7EA0-D5BC-415F-A6A1-8F71A7BB61D9 Q40147542-F24D03F6-7C1A-4123-9F94-377762786B5E Q40176792-B321A715-A471-4250-883A-7268CAD631F3 Q40178622-81FB4AD0-5A1F-4701-BAC6-29D9D945B99A Q40201364-D289B834-2468-4C1E-81F7-31501E771575 Q40298230-9BB9CCF4-1B29-4A5A-B6CD-C3E180DB257E Q40354550-8231400D-749B-4E20-959B-DEBDB1A5D40C

P2860

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

http://www.wikidata.org/entity/Q36624194

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

@ast

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

@en

type

label

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

@ast

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

@en

prefLabel

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

@ast

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

@en

P1433

Q36624194-6A22B801-6EE0-4238-89DC-78900E2DBA56

P1476

Q36624194-8C01A926-3753-48A8-8236-6C693B70E64D

P2093

Q36624194-1CA60128-8026-4B73-B54F-3EDE0E1F320C

Q36624194-258DD132-9EC1-4D92-B8A8-186F4E9F8169

Q36624194-262FB375-A2F0-4A61-AEFD-682802461277

Q36624194-28653CC7-2664-4044-8B1A-7AE3DAF36F16

Q36624194-2CCD970D-C86B-4577-B66A-C4BD3A63B1C2

Q36624194-31D56F5C-ADA6-444E-8E84-0AD3664B9C6C

Q36624194-3E54FA7E-DEA9-4530-96CE-F41B283D6B1B

Q36624194-5B85E98A-0706-44AD-96E2-D82603509B1F

Q36624194-5D0154E9-4253-4733-ACFC-939E19AE2264

Q36624194-638BAB89-7D62-4164-B702-2430A11C68A0

P2860

Q36624194-0276AD84-6663-44F7-BE1A-CB97B30E3259

Q36624194-062AF628-1996-4DB0-9989-3AC95AB7AB6E

Q36624194-07DDF004-17C2-4602-BBCF-CDC933A52168

Q36624194-09F5F581-1D39-4314-A76C-B01AFD407835

Q36624194-0B59338B-C900-47E3-BF01-7EA70BC58E6F

Q36624194-0BA1AA5D-4BD3-4531-A0B0-D3EE88708A42

Q36624194-0EDF53E2-23C2-4C25-8F94-DFA3CF570755

Q36624194-15297FC1-CA90-48BF-8404-C630C76F0EEE

Q36624194-15DC8794-3735-4347-84F8-EB673C6EA52A

Q36624194-33AF2AF9-45B1-492F-806F-6EAA9F5397E4

P304

Q36624194-413969D6-950A-4980-BB6A-9BD54AC327A9

P31

Q36624194-DA87D2D2-D074-42C0-B024-A6DC5A483B56

P356

Q36624194-178E5EF0-A0F9-4CEB-BCF8-74B03E6AAD50

P407

Q36624194-7F00A3DE-C886-4A01-BC99-595F25A32095

P433

Q36624194-D63AC2DE-A9EA-46D0-B200-4257538A6671

P478

Q36624194-6FD33390-1DBB-40F8-A7F0-F7C2CB42C656

P50

Q36624194-5EEABCB9-54C7-438F-8A4E-8A290C53795A

Q36624194-B47F1C90-B243-4E27-A25B-14733E6420E5

Q36624194-DF9F67C1-87D9-4F93-9EA6-1D65583BFCF1

Q36624194-F27427D7-638B-4DC6-A5D9-8F343535391C

Q36624194-FAE2FA61-279F-47A0-9BA0-8363A58FEB56

P577

Q36624194-582B5797-76F0-42E6-BC79-1B44135B6F96

P5875

Q36624194-DCD79B48-10FF-4F32-8C23-3266EC09DB40

P698

Q36624194-DC792717-0CCF-47C9-9BCE-39D29B1D2602

P932

Q36624194-15DCE1EF-3EB2-4BE4-AB86-2F4E1FAE0697

P356

SCIENCE.AAC9475

P1433

P1476

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

@en

P2093

Abigail B Ventura

http://www.w3.org/2001/XMLSchema#string

Alfred W Legasse

http://www.w3.org/2001/XMLSchema#string

Andrea N Selseth

http://www.w3.org/2001/XMLSchema#string

Andrew J McMichael

http://www.w3.org/2001/XMLSchema#string

Benjamin J Burwitz

http://www.w3.org/2001/XMLSchema#string

Colette M Hughes

http://www.w3.org/2001/XMLSchema#string

César A López

http://www.w3.org/2001/XMLSchema#string

Daniel Malouli

http://www.w3.org/2001/XMLSchema#string

David W Morrow

http://www.w3.org/2001/XMLSchema#string

Emily Ainslie

http://www.w3.org/2001/XMLSchema#string

P2860

HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities

Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines

The Universal Protein Resource (UniProt)

Improved side-chain torsion potentials for the Amber ff99SB protein force field

Simple and highly efficient BAC recombineering using galK selection

A highly sensitive selection method for directed evolution of homing endonucleases.

Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors

WebLogo: A Sequence Logo Generator

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.

P304

714-720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.AAC9475

http://www.w3.org/2001/XMLSchema#string

P407

P433

6274

http://www.w3.org/2001/XMLSchema#string

P478

351

http://www.w3.org/2001/XMLSchema#string

P50

Simon Brackenridge

Hannah R Sharpe

P577

2016-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291423968

http://www.w3.org/2001/XMLSchema#string

P698

26797147

http://www.w3.org/2001/XMLSchema#string

P932

4769032

http://www.w3.org/2001/XMLSchema#string